Michael Boubelı́k

1.8k total citations · 1 hit paper
19 papers, 1.5k citations indexed

About

Michael Boubelı́k is a scholar working on Molecular Biology, Genetics and Biotechnology. According to data from OpenAlex, Michael Boubelı́k has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Biotechnology. Recurrent topics in Michael Boubelı́k's work include Cancer Research and Treatments (5 papers), Virus-based gene therapy research (3 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). Michael Boubelı́k is often cited by papers focused on Cancer Research and Treatments (5 papers), Virus-based gene therapy research (3 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). Michael Boubelı́k collaborates with scholars based in Czechia, United States and Russia. Michael Boubelı́k's co-authors include Marilyn Monk, Sigrid A. Lehnert, Jana Pěknicová, Petr Dráber, Lubica Dráberová, Katarína Kološtová, Vladimír Bobek, Daniela Pintérová, Daniela Buckiová and Robert M. Hoffman and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Development.

In The Last Decade

Michael Boubelı́k

19 papers receiving 1.4k citations

Hit Papers

Temporal and regional changes in DNA methylation in the e... 1987 2026 2000 2013 1987 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Boubelı́k Czechia 12 989 504 236 211 157 19 1.5k
Séverine A. Degrelle France 24 753 0.8× 467 0.9× 255 1.1× 624 3.0× 499 3.2× 63 1.9k
Manabu Kawahara Japan 21 812 0.8× 449 0.9× 167 0.7× 275 1.3× 517 3.3× 96 1.5k
Florence Aubry France 17 1.1k 1.1× 425 0.8× 71 0.3× 172 0.8× 263 1.7× 20 1.7k
Carolina J. Jorgez United States 21 1.2k 1.2× 548 1.1× 165 0.7× 170 0.8× 830 5.3× 45 2.1k
Kenjiro Shirane Japan 18 1.9k 2.0× 544 1.1× 498 2.1× 228 1.1× 439 2.8× 33 2.4k
Masao Nagata Japan 26 1.3k 1.3× 924 1.8× 200 0.8× 527 2.5× 689 4.4× 106 2.7k
Yanfeng Lin China 16 1.3k 1.3× 454 0.9× 121 0.5× 57 0.3× 290 1.8× 65 1.8k
Steffen Schubert Germany 23 1.4k 1.4× 194 0.4× 85 0.4× 200 0.9× 161 1.0× 78 2.1k
Patricia A. Martin‐DeLeon United States 29 1.0k 1.0× 439 0.9× 78 0.3× 411 1.9× 623 4.0× 85 2.0k
Gerrit J. Bouma United States 24 1.1k 1.1× 444 0.9× 130 0.6× 564 2.7× 369 2.4× 73 1.8k

Countries citing papers authored by Michael Boubelı́k

Since Specialization
Citations

This map shows the geographic impact of Michael Boubelı́k's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Boubelı́k with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Boubelı́k more than expected).

Fields of papers citing papers by Michael Boubelı́k

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Boubelı́k. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Boubelı́k. The network helps show where Michael Boubelı́k may publish in the future.

Co-authorship network of co-authors of Michael Boubelı́k

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Boubelı́k. A scholar is included among the top collaborators of Michael Boubelı́k based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Boubelı́k. Michael Boubelı́k is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bobek, Vladimír, Katarína Kološtová, Daniela Pintérová, et al.. (2012). Tail spontaneous metastatic mouse model: comparison of metastatic potential of orthotopic and heterotopic models imaged by GFP and RFP protein.. PubMed. 25(6). 849–52. 1 indexed citations
2.
Kološtová, Katarína, Daniela Pintérová, Michael Boubelı́k, et al.. (2011). Wound healing gene therapy: cartilage regeneration induced by vascular endothelial growth factor plasmid. American Journal of Otolaryngology. 33(1). 68–74. 3 indexed citations
3.
Bobek, Vladimír, Katarína Kološtová, Daniela Pintérová, Michael Boubelı́k, & Robert M. Hoffman. (2011). Development of New Spontaneous Metastatic Heterotopic Model of Lewis Lung Carcinoma Imaged by GFP Expression. Cancer Investigation. 29(10). 692–695. 4 indexed citations
4.
Bobek, Vladimír, Katarína Kološtová, Daniela Pintérová, et al.. (2010). A clinically relevant, syngeneic model of spontaneous, highly metastatic B16 mouse melanoma.. PubMed. 30(12). 4799–803. 170 indexed citations
5.
Bobek, Vladimír, Katarína Kološtová, Michael Boubelı́k, et al.. (2005). Syngeneic lymph-node-targeting model of green fluorescent protein-expressing Lewis lung carcinoma. Clinical & Experimental Metastasis. 21(8). 705–708. 11 indexed citations
6.
Bobek, Vladimír, et al.. (2005). Streptokinase increases the sensitivity of colon cancer cells to chemotherapy by gemcitabine and cis-platine in vitro. Cancer Letters. 237(1). 95–101. 5 indexed citations
7.
Dráberová, Lubica, S̆árka S̆ı́mová, Petr Heneberg, et al.. (2004). Negative Regulation of Mast Cell Signaling and Function by the Adaptor LAB/NTAL. The Journal of Experimental Medicine. 200(8). 1001–1014. 114 indexed citations
8.
Bobek, Vladimír, Jiřı́ Plachý, Daniela Pintérová, et al.. (2004). Development of a green fluorescent protein metastatic-cancer chick-embryo drug-screen model. Clinical & Experimental Metastasis. 21(4). 347–352. 32 indexed citations
9.
Dráberová, Lubica, et al.. (2003). Exogenous Administration of Gangliosides Inhibits FcεRI-Mediated Mast Cell Degranulation by Decreasing the Activity of Phospholipase Cγ. The Journal of Immunology. 171(7). 3585–3593. 19 indexed citations
10.
Pěknicová, Jana, et al.. (2003). Effects of p-nonylphenol and resveratrol on body and organ weight and in vivo fertility of outbred CD-1 mice. Reproductive Biology and Endocrinology. 1(1). 30–30. 69 indexed citations
12.
Pěknicová, Jana, et al.. (2002). Effect of an Endocrine Disruptor on Mammalian Fertility. Application of Monoclonal Antibodies against Sperm Proteins as Markers for Testing Sperm Damage. American Journal of Reproductive Immunology. 47(5). 311–318. 35 indexed citations
13.
Dráber, Petr, Lubica Dráberová, Martina Kovářová, et al.. (2001). Lipid Rafts and Their Role in Signal Transduction-Mast Cells as a Model. Trends in Glycoscience and Glycotechnology. 13(71). 261–279. 9 indexed citations
14.
Surviladze, Zurab, Lubica Dráberová, Martina Kovářová, Michael Boubelı́k, & Petr Dráber. (2001). Differential sensitivity to acute cholesterol lowering of activation mediated via the high-affinity IgE receptor and Thy-1 glycoprotein. European Journal of Immunology. 31(1). 1–10. 53 indexed citations
15.
Zı́dek, Zdeňek, Daniela Franková, & Michael Boubelı́k. (2000). Genetic variation in in-vitro cytokine-induced production of nitric oxide by murine peritoneal macrophages.. Pharmacogenetics. 10(6). 493–501. 12 indexed citations
17.
Boubelı́k, Michael, Lubica Dráberová, & Petr Dráber. (1996). Carbohydrate-Mediated Sorting in Aggregating Embryonal Carcinoma Cells. Biochemical and Biophysical Research Communications. 224(2). 283–288. 22 indexed citations
18.
19.
Monk, Marilyn, Michael Boubelı́k, & Sigrid A. Lehnert. (1987). Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development. 99(3). 371–382. 886 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026